个人中心 - 老虎社区

每天有新高

IP属地：浙江

帖子 · 93帖子 · 93
关注 · 0关注 · 0
粉丝 · 0粉丝 · 0

- 每天有新高每天有新高
  ·08-16
  $Allogene Therapeutics Inc.(ALLO)$
  482 评论
  点赞
  分享
  举报
- 每天有新高每天有新高
  ·07-10
  $Sangamo Therapeutics Inc(SGMO)$
  920 评论
  点赞
  分享
  举报
- 每天有新高每天有新高
  ·2023-12-07
  $Baudax Bio, Inc.(BXRX)$ 这股就四个字“不停地跌
  1,493 评论
  点赞
  分享
  举报
- 每天有新高每天有新高
  ·2023-11-10
  $Sangamo BioSciences(SGMO)$ 这股要跌到退市吗？
  1,751 评论
  1
  分享
  举报
- 每天有新高每天有新高
  ·2023-11-04
  $Sangamo BioSciences(SGMO)$ 垃圾
  1,449 评论
  点赞
  分享
  举报
- 每天有新高每天有新高
  ·2023-08-08
  $Sangamo BioSciences(SGMO)$ 快跑，盘后会大跌
  2,020 评论
  点赞
  分享
  举报
- 每天有新高每天有新高
  ·2023-06-02
  $Autolus Therapeutics PLC(AUTL)$ 见光死的利好
  2,223 评论
  点赞
  分享
  举报
- 每天有新高每天有新高
  ·2023-05-26
  $DLocal Limited(DLO)$ 啥利空？
  2,336 1
  点赞
  分享
  举报
- 每天有新高每天有新高
  ·2023-05-09
  说说你对这篇新闻的看法...
  Amyris expects Q1 revenue of $56M, consensus at $60.43M
  Amyris (NASDAQ:AMRS) expects to deliver Q1 2023 total revenue of ~$56M, up from ~$50M stated in Q4 e
  Amyris expects Q1 revenue of $56M, consensus at $60.43M
  1,587 评论
  点赞
  分享
  举报
- 每天有新高每天有新高
  ·2023-03-10
  $Sangamo BioSciences(SGMO)$ 阴跌模式开启，至少到1.5吧！
  2,109 评论
  2
  分享
  举报
暂无关注

热议股票

关于我们·老虎社区守则·老虎社区账号管理规范·老虎社区服务协议·老虎社区隐私政策

公司名称：北京至简风宜信息技术有限公司

违法和不良信息投诉：010-5681-3562（工作时间9:30-18:30）

邮箱：service@laohu8.com

老虎社区侵权投诉指引

中国互联网举报中心·北京互联网举报中心

网络谣言曝光台·扫黄打非举报中心

网络110报警服务

© 2018-2024 老虎社区版权所有

营业执照：91110105MA01A4U55R

ICP备：京ICP备18016422号

网安备：京公网安备11010502036490

qrcode

关注我们

{"i18n":{"language":"zh_CN"},"isCurrentUser":false,"userPageInfo":{"id":"3563871956693501","uuid":"3563871956693501","gmtCreate":1600777933611,"gmtModify":1607578057393,"name":"每天有新高","pinyin":"mtyxgmeitianyouxingao","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.tigerbbs.com/872fc34821e8b13224b0d415b62b08ab","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":1,"headSize":26,"tweetSize":93,"questionSize":0,"limitLevel":999,"accountStatus":3,"level":{"id":3,"name":"书生虎","nameTw":"書生虎","represent":"努力向上","factor":"发布10条非转发主帖,其中5条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-3","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"偶像虎友","description":"加入老虎社区1500天","bigImgUrl":"https://static.tigerbbs.com/8b40ae7da5bf081a1c84df14bf9e6367","smallImgUrl":"https://static.tigerbbs.com/f160eceddd7c284a8e1136557615cfad","grayImgUrl":"https://static.tigerbbs.com/11792805c468334a9b31c39f95a41c6a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.11.01","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001}],"userBadgeCount":1,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":1,"crmLevelSwitch":0,"location":"浙江","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":1,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":339215242481944,"gmtCreate":1723820379553,"gmtModify":1723820380655,"author":{"id":"3563871956693501","authorId":"3563871956693501","name":"每天有新高","avatar":"https://static.tigerbbs.com/872fc34821e8b13224b0d415b62b08ab","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3563871956693501","authorIdStr":"3563871956693501"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/ALLO\">$Allogene Therapeutics Inc.(ALLO)$</a>&nbsp;","listText":"<a href=\"https://laohu8.com/S/ALLO\">$Allogene Therapeutics Inc.(ALLO)$</a>&nbsp;","text":"$Allogene Therapeutics Inc.(ALLO)$","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/339215242481944","isVote":1,"tweetType":1,"viewCount":482,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":326136168018224,"gmtCreate":1720624751467,"gmtModify":1720624752601,"author":{"id":"3563871956693501","authorId":"3563871956693501","name":"每天有新高","avatar":"https://static.tigerbbs.com/872fc34821e8b13224b0d415b62b08ab","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3563871956693501","authorIdStr":"3563871956693501"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/SGMO\">$Sangamo Therapeutics Inc(SGMO)$</a> &nbsp; &nbsp; &nbsp; &nbsp;&nbsp; &nbsp;","listText":"<a href=\"https://laohu8.com/S/SGMO\">$Sangamo Therapeutics Inc(SGMO)$</a> &nbsp; &nbsp; &nbsp; &nbsp;&nbsp; &nbsp;","text":"$Sangamo Therapeutics Inc(SGMO)$","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/326136168018224","isVote":1,"tweetType":1,"viewCount":920,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":249195482194024,"gmtCreate":1701878435593,"gmtModify":1701878436521,"author":{"id":"3563871956693501","authorId":"3563871956693501","name":"每天有新高","avatar":"https://static.tigerbbs.com/872fc34821e8b13224b0d415b62b08ab","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3563871956693501","authorIdStr":"3563871956693501"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/BXRX\">$Baudax Bio, Inc.(BXRX)$&nbsp;</a>这股就四个字“不停地跌","listText":"<a href=\"https://laohu8.com/S/BXRX\">$Baudax Bio, Inc.(BXRX)$&nbsp;</a>这股就四个字“不停地跌","text":"$Baudax Bio, Inc.(BXRX)$ 这股就四个字“不停地跌","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/249195482194024","isVote":1,"tweetType":1,"viewCount":1493,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":239710810562648,"gmtCreate":1699546912250,"gmtModify":1699546913358,"author":{"id":"3563871956693501","authorId":"3563871956693501","name":"每天有新高","avatar":"https://static.tigerbbs.com/872fc34821e8b13224b0d415b62b08ab","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3563871956693501","authorIdStr":"3563871956693501"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/SGMO\">$Sangamo BioSciences(SGMO)$&nbsp;</a>这股要跌到退市吗？","listText":"<a href=\"https://laohu8.com/S/SGMO\">$Sangamo BioSciences(SGMO)$&nbsp;</a>这股要跌到退市吗？","text":"$Sangamo BioSciences(SGMO)$ 这股要跌到退市吗？","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/239710810562648","isVote":1,"tweetType":1,"viewCount":1751,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":237660287594688,"gmtCreate":1699055297663,"gmtModify":1699063985570,"author":{"id":"3563871956693501","authorId":"3563871956693501","name":"每天有新高","avatar":"https://static.tigerbbs.com/872fc34821e8b13224b0d415b62b08ab","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3563871956693501","authorIdStr":"3563871956693501"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/SGMO\">$Sangamo BioSciences(SGMO)$&nbsp;</a>垃圾","listText":"<a href=\"https://laohu8.com/S/SGMO\">$Sangamo BioSciences(SGMO)$&nbsp;</a>垃圾","text":"$Sangamo BioSciences(SGMO)$ 垃圾","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/237660287594688","isVote":1,"tweetType":1,"viewCount":1449,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":206764979642616,"gmtCreate":1691509119510,"gmtModify":1691509120549,"author":{"id":"3563871956693501","authorId":"3563871956693501","name":"每天有新高","avatar":"https://static.tigerbbs.com/872fc34821e8b13224b0d415b62b08ab","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3563871956693501","authorIdStr":"3563871956693501"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/SGMO\">$Sangamo BioSciences(SGMO)$&nbsp;</a>快跑，盘后会大跌","listText":"<a href=\"https://laohu8.com/S/SGMO\">$Sangamo BioSciences(SGMO)$&nbsp;</a>快跑，盘后会大跌","text":"$Sangamo BioSciences(SGMO)$ 快跑，盘后会大跌","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/206764979642616","isVote":1,"tweetType":1,"viewCount":2020,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":183048205336664,"gmtCreate":1685709085761,"gmtModify":1685709086731,"author":{"id":"3563871956693501","authorId":"3563871956693501","name":"每天有新高","avatar":"https://static.tigerbbs.com/872fc34821e8b13224b0d415b62b08ab","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3563871956693501","authorIdStr":"3563871956693501"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/AUTL\">$Autolus Therapeutics PLC(AUTL)$&nbsp;</a>见光死的利好","listText":"<a href=\"https://laohu8.com/S/AUTL\">$Autolus Therapeutics PLC(AUTL)$&nbsp;</a>见光死的利好","text":"$Autolus Therapeutics PLC(AUTL)$ 见光死的利好","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/183048205336664","isVote":1,"tweetType":1,"viewCount":2223,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":655307365,"gmtCreate":1685113712257,"gmtModify":1685113714169,"author":{"id":"3563871956693501","authorId":"3563871956693501","name":"每天有新高","avatar":"https://static.tigerbbs.com/872fc34821e8b13224b0d415b62b08ab","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3563871956693501","authorIdStr":"3563871956693501"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/DLO\">$DLocal Limited(DLO)$&nbsp;</a>啥利空？&nbsp;","listText":"<a href=\"https://laohu8.com/S/DLO\">$DLocal Limited(DLO)$&nbsp;</a>啥利空？&nbsp;","text":"$DLocal Limited(DLO)$ 啥利空？","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/655307365","isVote":1,"tweetType":1,"viewCount":2336,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"4133448854404800","authorId":"4133448854404800","name":"Pearl178","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"idStr":"4133448854404800","authorIdStr":"4133448854404800"},"content":"我也挺好奇… 是不是要翻翻外网","text":"我也挺好奇… 是不是要翻翻外网","html":"我也挺好奇… 是不是要翻翻外网"}],"imageCount":0,"langContent":"CN","totalScore":0},{"id":656632673,"gmtCreate":1683639698592,"gmtModify":1683639700187,"author":{"id":"3563871956693501","authorId":"3563871956693501","name":"每天有新高","avatar":"https://static.tigerbbs.com/872fc34821e8b13224b0d415b62b08ab","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3563871956693501","authorIdStr":"3563871956693501"},"themes":[],"htmlText":"说说你对这篇新闻的看法...","listText":"说说你对这篇新闻的看法...","text":"说说你对这篇新闻的看法...","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/656632673","repostId":"2329850294","repostType":2,"repost":{"id":"2329850294","pubTimestamp":1682348357,"share":"https://www.laohu8.com/m/news/2329850294?lang=&edition=full","pubTime":"2023-04-24 22:59","market":"us","language":"en","title":"Amyris expects Q1 revenue of $56M, consensus at $60.43M","url":"https://stock-news.laohu8.com/highlight/detail?id=2329850294","media":"seekingalpha","summary":"Amyris (NASDAQ:AMRS) expects to deliver Q1 2023 total revenue of ~$56M, up from ~$50M stated in Q4 e","content":"<html><body><ul> <li>Amyris (<span>NASDAQ:AMRS</span>) expects to deliver Q1 2023 total revenue of ~$56M, up from ~$50M stated in Q4 earnings call vs. consensus of $60.43M.</li> <li>Gross profit and operating expense are expected to be sequentially significantly better compared to Q4 2022.</li> <li>The Co. continues<span> to execute its strategic agenda with a keen focus on cost efficiency and capital structure and the liquidity required to self-fund its business plan.</span> </li> <li>\"Our liquidity plan includes significant cost savings, attaining the estimated $335M of earnouts and milestone payments over the next three years from current strategic agreements and executing on an estimated $200M from additional transactions this year.\" said John Melo, President and CEO.</li> <li>AMRS is <span>+8.6%</span> to $0.86.</li> </ul></body></html>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Amyris expects Q1 revenue of $56M, consensus at $60.43M</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAmyris expects Q1 revenue of $56M, consensus at $60.43M\n</h2>\n\n<h4 class=\"meta\">\n\n\n2023-04-24 22:59 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3959123-amyris-sees-q1-revenue-56m-consensus-6043m><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Amyris (NASDAQ:AMRS) expects to deliver Q1 2023 total revenue of ~$56M, up from ~$50M stated in Q4 earnings call vs. consensus of $60.43M. Gross profit and operating expense are expected to be ...</p>\n\n<a href=\"https://seekingalpha.com/news/3959123-amyris-sees-q1-revenue-56m-consensus-6043m\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AMRS":"阿米瑞斯"},"source_url":"https://seekingalpha.com/news/3959123-amyris-sees-q1-revenue-56m-consensus-6043m","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"2329850294","content_text":"Amyris (NASDAQ:AMRS) expects to deliver Q1 2023 total revenue of ~$56M, up from ~$50M stated in Q4 earnings call vs. consensus of $60.43M. Gross profit and operating expense are expected to be sequentially significantly better compared to Q4 2022. The Co. continues to execute its strategic agenda with a keen focus on cost efficiency and capital structure and the liquidity required to self-fund its business plan.  \"Our liquidity plan includes significant cost savings, attaining the estimated $335M of earnouts and milestone payments over the next three years from current strategic agreements and executing on an estimated $200M from additional transactions this year.\" said John Melo, President and CEO. AMRS is +8.6% to $0.86.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1587,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":627546014,"gmtCreate":1678453590939,"gmtModify":1678453593583,"author":{"id":"3563871956693501","authorId":"3563871956693501","name":"每天有新高","avatar":"https://static.tigerbbs.com/872fc34821e8b13224b0d415b62b08ab","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3563871956693501","authorIdStr":"3563871956693501"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/SGMO\">$Sangamo BioSciences(SGMO)$&nbsp;</a>阴跌模式开启，至少到1.5吧！","listText":"<a href=\"https://laohu8.com/S/SGMO\">$Sangamo BioSciences(SGMO)$&nbsp;</a>阴跌模式开启，至少到1.5吧！","text":"$Sangamo BioSciences(SGMO)$ 阴跌模式开启，至少到1.5吧！","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/627546014","isVote":1,"tweetType":1,"viewCount":2109,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"defaultTab":"following","isTTM":false}